A Long-Term Monitoring Study of the IMT-002 Patients

Sponsor
VisionCare, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT00976235
Collaborator
(none)
129
28
1
59
4.6
0.1

Study Details

Study Description

Brief Summary

This is a 5-year study of patients implanted with the Implantable Miniature Telescope (IMT by Dr. Isaac Lipshitz) under Protocol IMT-002. All patients implanted with the telescope prosthesis who enrolled in the IMT-002 trial were asked to participate in this study to monitor long-term safety. Patients will undergo examinations at six-month intervals up to a total of 5 years following implantation.

Condition or Disease Intervention/Treatment Phase
  • Device: IMT - Implantable Miniature Telescope
N/A

Detailed Description

Every 6 months, manifest refraction, visual acuity, intraocular pressure, slit lamp examination, endothelial cell density, device failures, complications and adverse events will be assessed.

Study Design

Study Type:
Interventional
Actual Enrollment :
129 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Five Year Follow up of IMT-002 Patients; A Long-Term Monitoring Study of IMT-002 Patients
Study Start Date :
Jun 1, 2006
Actual Primary Completion Date :
May 1, 2011
Actual Study Completion Date :
May 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: IMT

Device: IMT - Implantable Miniature Telescope
Implantation of the telescope prosthesis (performed under the initial study)

Outcome Measures

Primary Outcome Measures

  1. Long term safety (Intraocular pressure, Slit lamp, Endothelial Cell Density, Visual Acuity, Complications, Adverse Events and Device Failures) [5 years from implantation]

Eligibility Criteria

Criteria

Ages Eligible for Study:
55 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients must have participated in the IMT-002 trial.

  • Patients must be able to understand and comply with the requirements of the clinical study, and be able to abide by the requirements and restrictions of the study.

  • Patients must be able to provide voluntary informed consent, and must sign and be given a copy of the written Informed Consent form.

Exclusion Criteria:
  • Patients who have not participated in the IMT-002 trial.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Retina Centers P.C. Tucson Arizona United States 85704
2 University of California at Irvine Irvine California United States 92697
3 Altos Eye Physician Los Altos California United States 94024
4 Doheny Retina Institute - University of Southern California Los Angeles California United States 90033
5 Sarasota Retinal Institute Sarasota Florida United States 34239
6 Emory Eye Center Atlanta Georgia United States 30322
7 Kraft Eye Institute Chicago Illinois United States 60634
8 Paducah Retinal Center Paducah Kentucky United States 42001
9 Wilmer Ophthalmological Institute Baltimore Maryland United States 21287-9277
10 Retina Group of Washington Chevy Chase Maryland United States 20815
11 Massachusetts Eye & Ear Infirmary Boston Massachusetts United States 02114
12 Ophthalmic Consultants of Boston Boston Massachusetts United States 02114
13 W.K. Kellogg Eye Center Ann Arbor Michigan United States 48105
14 Associated Retinal Consultants Royal Oak Michigan United States 48073
15 Associated Eye Care Stillwater Minnesota United States 55082
16 Discover Vision Centers Independence Missouri United States 64055
17 Manhattan Eye & Ear New York New York United States 10021
18 Southeast Clinical Research Charlotte North Carolina United States 28210
19 Duke University Eye Center Durham North Carolina United States 27710
20 Retina Associates of Cleveland Beachwood Ohio United States 44122
21 Dean A. McGee Eye Institute Oklahoma City Oklahoma United States 73104
22 Fine, Hoffman & Packer Eugene Oregon United States 97401
23 Wills Eye Hospital Philadelphia Pennsylvania United States 19107
24 Vitreoretinal Foundation Memphis Tennessee United States 78240
25 Vanderbilt University Nashville Tennessee United States 37232
26 Baylor College of Medicine Houston Texas United States 77030
27 Medical Center Ophthalmology San Antonio Texas United States 78240
28 Medical College of Wisconsin Milwaukee Wisconsin United States 53226

Sponsors and Collaborators

  • VisionCare, Inc.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
VisionCare, Inc.
ClinicalTrials.gov Identifier:
NCT00976235
Other Study ID Numbers:
  • IMT-002-LTM
First Posted:
Sep 14, 2009
Last Update Posted:
Nov 6, 2017
Last Verified:
Nov 1, 2017
Keywords provided by VisionCare, Inc.
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 6, 2017